A
Aline R. Matos
Researcher at Oswaldo Cruz Foundation
Publications - 26
Citations - 543
Aline R. Matos is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 11, co-authored 19 publications receiving 335 citations. Previous affiliations of Aline R. Matos include Federal University of Rio de Janeiro.
Papers
More filters
Journal ArticleDOI
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.
Natalia Fintelman-Rodrigues,Carolina Q. Sacramento,Carlyle Ribeiro Lima,Franklin Souza da Silva,André C. Ferreira,Mayara Mattos,Caroline S. de Freitas,Vinicius Cardoso Soares,Suelen da Silva Gomes Dias,Jairo R. Temerozo,Milene D. Miranda,Aline R. Matos,Fernando A. Bozza,Nicolas Carels,Carlos Roberto Alves,Marilda M. Siqueira,Patrícia T. Bozza,Thiago Moreno L. Souza +17 more
TL;DR: ATV inhibits SARS-CoV-2 replication, alone or in combination with ritonavir (RTV) in Vero cells and a human pulmonary epithelial cell line, and impaired virus-induced enhancement of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) levels.
Posted ContentDOI
SARS-CoV-2 genomes recovered by long amplicon tiling multiplex approach using nanopore sequencing and applicable to other sequencing platforms
Paola Cristina Resende,Paola Cristina Resende,Fernando Couto Motta,Sunando Roy,Luciana Appolinario,Allison Fabri,Joilson Xavier,Kathryn A. Harris,Aline R. Matos,Braulia Costa Caetano,Maria Orgeswalska,Milene Miranda,Cristiana C. Garcia,André Luiz de Abreu,Rachel Williams,Judith Breuer,Judith Breuer,Marilda M. Siqueira,Ministério da Saúde. Coordenação Nacional de Laboratórios. Brasília, Df, Brasil. +18 more
TL;DR: Three protocols are described using a unique primer set designed to recover long reads of SARS-CoV-2 directly from total RNA extracted from clinical samples, useful, accessible and adaptable to laboratories with varying resources and access to distinct sequencing methods.
Journal ArticleDOI
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Tatiana Martins Tilli,Kivvi Duarte de Mello,Luciana Ferreira,Aline R. Matos,Maria Thereza S. Accioly,Paulo Antonio Faria,Akeila Bellahcene,Vincent Castronovo,Etel Rodrigues Pereira Gimba,Etel Rodrigues Pereira Gimba +9 more
TL;DR: This work aims to investigate the roles of each OPN‐SI in prostate cancer (PCa) progression by using in vivo and in vitro functional assays.
Posted ContentDOI
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
Natalia Fintelman-Rodrigues,Carolina Q. Sacramento,Carlyle Ribeiro Lima,Franklin Souza da Silva,André C. Ferreira,Mayara Mattos,Caroline S. de Freitas,Vinicius Cardoso Soares,Suelen da Silva Gomes Dias,Jairo R. Temerozo,Milene Miranda,Aline R. Matos,Fernando A. Bozza,Nicolas Carels,Carlos Roberto Alves,Marilda M. Siqueira,Patrícia T. Bozza,Thiago Moreno L. Souza +17 more
TL;DR: Morel et al. as discussed by the authors presented a study that was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and the National Institutes of Science and Technology Program (INCT-IDPN).
Journal ArticleDOI
The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer.
Ana Emília Goulart Lemos,Ana Emília Goulart Lemos,Aline R. Matos,Luciana Ferreira,Etel Rodrigues Pereira Gimba +4 more
TL;DR: Literature data indicate aberrant expression and dysregulated activity of PCA3, suggesting PCA 3 as a promising relevant target that should be even further evaluated on its applicability for PCa detection and management.